Moilanen AM, Riikonen R, Oksala R. et al: Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapies. Sci Rep 5: 12007, 2015
Moilanen A, Riikonen R, Oksala R, et al: ODM-201, new generation antiandrogen with excellent anti-androgenic and antitumor activity in nonclinical models of CRPC. European Journal of Cancer; 2013 : ELSEVIER SCI LTD THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB ....